Measuring the Severity of Infantile Hemangiomas: Instrument Development and Reliability | Dermatology | JAMA Dermatology | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.239.150.57. Please contact the publisher to request reinstatement.
1.
Chang LC, Haggstrom AN, Drolet BA,  et al; Hemangioma Investigator Group.  Growth characteristics of infantile hemangiomas: implications for management.  Pediatrics. 2008;122(2):360-36718676554PubMedGoogle Scholar
2.
Haggstrom AN, Drolet BA, Baselga E,  et al.  Prospective study of infantile hemangiomas: clinical characteristics predicting complications and treatment.  Pediatrics. 2006;118(3):882-88716950977PubMedGoogle Scholar
3.
Chamlin SL, Haggstrom AN, Drolet BA,  et al.  Multicenter prospective study of ulcerated hemangiomas [published correction appears in J Pediatr. 2008;152(4):597].  J Pediatr. 2007;151(6):684-689Google Scholar
4.
Drolet BA, Chamlin SL, Garzon MC,  et al.  Prospective study of spinal anomalies in children with infantile hemangiomas of the lumbosacral skin.  J Pediatr. 2010;157(5):789-79420828712PubMedGoogle Scholar
5.
Haggstrom AN, Garzon MC, Baselga E,  et al.  Risk for PHACE syndrome in infants with large facial hemangiomas.  Pediatrics. 2010;126(2):e418-e426Accessed November 4, 201120643720PubMedGoogle Scholar
6.
Metry D, Heyer G, Hess C,  et al; PHACE Syndrome Research Conference.  PHACE Syndrome Research Conference. Consensus statement on diagnostic criteria for PHACE syndrome.  Pediatrics. 2009;124(5):1447-145619858157PubMedGoogle Scholar
7.
Iacobas I, Burrows PE, Frieden IJ,  et al.  LUMBAR: association between cutaneous infantile hemangiomas of the lower body and regional congenital anomalies.  J PediatrGoogle Scholar
Study
Feb 2012

Measuring the Severity of Infantile Hemangiomas: Instrument Development and Reliability

Author Affiliations

Author Affiliations: Departments of Dermatology and Pediatrics (Dr Haggstrom) and Public Health and Pediatrics (Dr Swigonski), Indiana University School of Medicine, Indianapolis; Departments of Medical Social Sciences (Ms Beaumont and Drs Lai and Cella) and Pediatrics and Dermatology (Drs Mancini and Chamlin), Northwestern University Feinberg School of Medicine, Chicago, Illinois; Divisions of Hematology/Oncology (Dr Adams) and Pediatric Dermatology (Dr Lucky), Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; Department of Dermatology, Medical College of Wisconsin, Milwaukee (Drs Drolet, Holland, and Siegel); Departments of Dermatology and Pediatrics, University of California, San Francisco School of Medicine, San Francisco (Dr Frieden); Department of Dermatology, Columbia University, New York, New York (Drs Garzon and Morel); Section of Dermatology, Children's Mercy Hospital and Clinics, Kansas City, Missouri (Drs Horii, Newell, and Nopper); and Department of Dermatology, Baylor College of Medicine, Houston, Texas (Dr Metry).

Arch Dermatol. 2012;148(2):197-202. doi:10.1001/archdermatol.2011.926
Abstract

Objectives To develop instruments that measure the severity of infantile hemangiomas (Hemangioma Severity Scale [HSS]) and the complications of infantile hemangiomas for longitudinal use (Hemangioma Dynamic Complication Scale [HDCS]).

Design Instrument development and reliability study.

Setting Academic research.

Participants The HSS and the HDCS were developed through the collaborative effort of members of the Hemangioma Investigator Group Research Core, an expert multi-institutional research group. After development of the scales, 13 pediatric dermatologists used the HSS to score 20 different hemangiomas. In addition, 12 pediatric dermatologists used the HDCS to score hemangioma-related complications for 24 clinical scenarios. Interrater and intrarater reliability was measured for both scales.

Main Outcome Measures Interrater and intrarater reliability.

Results For the HSS, interrater reliability and intrarater reliability exceeded 99%. Similarly, the HDCS had a high rate of interrater agreement; for individual items, agreement among raters was 67% to 100%, with most clinical scenarios demonstrating greater than 90% agreement. Intrarater reliability was excellent for all individual items of the HDCS.

Conclusion The HSS and the HDCS are reliable scales that can be used to measure the severity of infantile hemangiomas, including the severity of complications for longitudinal use.

×